Audiological findings in patients treated with radiotherapy for head and neck tumors.

UNLABELLED: Radiotherapy has been widely used given its increase in the successful outcomes and cure of some cancers. AIM: To evaluate the functionality of the auditory system in patients who underwent radiotherapy treatment for head and neck tumors. MATERIALS AND METHODS: From May 2007 to May 2008, otorhinolaryngological and audiological evaluation (Pure Tone Audiometry (air and bone conduction), Speech Audiometry, Tympanometry, Acoustic Reflex testing and Distortion Product Otoacoustic Emissions) were performed in 19 patients diagnosed with head and neck neoplasia and treated with radiotherapy. Prospective case series study. RESULTS: 10.5% left ears and 26.3% right ears had bilateral hearing loss soon after radiotherapy according to ASHA criteria. CONCLUSIONS: Radiotherapy treatment for head and neck cancer has ototoxic effects. Early programs of auditory rehabilitation should be offered to these patients.

Achados audiológicos em pacientes tratados com radioterapia para tumores de cabeça e pescoço / Audiological findings in pacients treated with radiotherapy for head and neck tumors

A radioterapia é uma modalidade terapêutica muito utilizada, uma vez que o aumento de resultados satisfatórios e a cura de algumas neoplasias através deste tipo de tratamento estão sendo observados. OBJETIVO: Avaliar a funcionalidade do sistema auditivo em pacientes submetidos ao tratamento radioterápico em região de cabeça e pescoço. MATERIAL E MÉTODO: Estudo realizado no período de maio de 2007 a maio de 2008. Foram realizadas avaliações otorrinolaringológicas e audiológicas como audiometria tonal limiar por via aérea e óssea, audiometria vocal, timpanometria, pesquisa do reflexo do estapédio e Emissões Otoacústicas Evocadas por Produto de Distorção em 19 pacientes com diagnóstico de neoplasia em região de cabeça e pescoço e indicação do tratamento radioterápico. Estudo de série prospectivo. RESULTADOS: 10,5 por cento orelhas esquerdas e 26,3 por cento orelhas direitas apresentaram diminuição dos limares auditivos tonais logo após o término do tratamento radioterápico, segundo os critérios da ASHA. CONCLUSÃO: O tratamento radioterápico apresentou efeitos ototóxicos quando realizado em região de cabeça e pescoço. Programas de monitoramento audiológico e reabilitação auditiva precoce devem ser oferecidos aos pacientes submetidos a esse tipo de tratamento.

Radiotherapy has been widely used given its increase in the successful outcomes and cure of some cancers. AIM: To evaluate the functionality of the auditory system in patients who underwent radiotherapy treatment for head and neck tumors. MATERIALS AND METHODS: From May 2007 to May 2008, otorhinolaryngological and audiological evaluation (Pure Tone Audiometry (air and bone conduction), Speech Audiometry, Tympanometry, Acoustic Reflex testing and Distortion Product Otoacoustic Emissions) were performed in 19 patients diagnosed with head and neck neoplasia and treated with radiotherapy. Prospective case series study. RESULTS: 10.5 percent left ears and 26.3 percent right ears had bilateral hearing loss soon after radiotherapy according to ASHA criteria. CONCLUSIONS: Radiotherapy treatment for head and neck cancer has ototoxic effects. Early programs of auditory rehabilitation should be offered to these patients.

Audiological findings in patients treated with radio- and concomitant chemotherapy for head and neck tumors.

OBJECTIVE: To evaluate the functionality of the auditory system in patients who underwent radiotherapy and chemotherapy treatment with cisplatin to treat head and neck tumors. STUDY DESIGN: Case series with planned data collection. SETTING: From May 2007 to May 2008 by the Department of Otorhinolaryngology and the Department of Oncology/Radiotherapy at Faculdade de Medicina de Marília. SUBJECTS AND METHODS: Audiological evaluation (Pure Tone Audiometry (air and bone conduction), Speech Audiometry, Tympanometry, Acoustic Reflex testing and Distortion Product Otoacoustic Emissions) was performed in 17 patients diagnosed with head and neck neoplasia and treated with chemotherapy, using cisplatin, and radiotherapy. RESULTS: 12 left ears (70.5%) and 11 right ears (64.7%) presented bilateral decreased hearing soon after the treatment for the frequency 1 kHz (mild auditory damage) and for the frequency 8 kHz (more significant auditory damage). CONCLUSION: Patients with head and neck cancer submitted to the conventional radiotherapy treatment, combined with the chemotherapy with cisplatin, presented a high incidence of decreased hearing by the end of treatment. Strong evidence was observed linking auditory alteration to the amount of radiotherapy treatment.